SCHEMBL22034703

SCHEMBL22034703

C[SiH](C)C(C)(C)COCCO[C@H]1CO[C@H]2[C@@H]1OC[C@H]2OCCO[Si](C)(C)C(C)(C)C

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22034705 0.85 DUT (0.31) —
SCHEMBL22262500 0.81 DUT (0.32) —
SCHEMBL22262713 0.79 — —
SCHEMBL22034475 0.76 BCHE (0.46) —
SCHEMBL22034476 0.71 BCHE (0.48) —
SCHEMBL22034436 0.71 BCHE (0.48) —
SCHEMBL15881416 0.63 — —
SCHEMBL11580466 0.62 DUT (0.42) —
SCHEMBL6670981 0.61 ALDH1A1 (0.34) —
SCHEMBL23251029 0.61 KDM4E (0.31) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220041641-A1 QUATERNARY AMMONIUM SALTS AS INHIBITORS OF TRIMETHYLAMINE PRODUCTION SENDA BIOSCIENCES INC (US) 2022-02-10 — — US disclosed
EP-3891751-A1 QUATERNARY AMMONIUM SALTS AS INHIBITORS OF TRIMETHYLAMINE PRODUCTION Senda Biosciences, Inc. (US) 2021-10-13 — — EP disclosed
WO-2020118238-A1 QUATERNARY AMMONIUM SALTS AS INHIBITORS OF TRIMETHYLAMINE PRODUCTION KINTAI THERAPEUTICS, INC. (US) 2020-06-11 — — WO disclosed
Send feedback